The distribution and characteristics of LDL receptor mutations in China: A systematic review

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Jiang, Long ^a   Sun, Li Yuan ^a   Dai, Yan Fang ^a   Yang, Shi Wei ^a   Zhang, Feng ^b,c   Wang, Lu Ya ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b Chinese Academy of Sciences   (China)

^c NORTHEAST NORMAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

LIPID; LOW DENSITY LIPOPROTEIN RECEPTOR;

BLOOD; CHINA; COMPUTER SIMULATION; GENETIC DATABASE; GENETICS; HONG KONG; HUMAN; HYPERLIPOPROTEINEMIA TYPE II; META ANALYSIS; MUTATION; MUTATION RATE; PHENOTYPE; TAIWAN;

CHINA; COMPUTER SIMULATION; DATABASES, GENETIC; HONG KONG; HUMANS; HYPERLIPOPROTEINEMIA TYPE II; LIPIDS; MUTATION; MUTATION RATE; PHENOTYPE; RECEPTORS, LDL; TAIWAN;

EID: 84948187228     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep17272     Document Type: Review

References (50)

1. Watts, G. F. et al. Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation. Int J Cardiol 171, 309-325 (2014).
2. Starr, B. et al. Development of sensitive and specific age- and gender-specific low-density lipoprotein cholesterol cutoffs for diagnosis of first-degree relatives with familial hypercholesterolaemia in cascade testing. Clin Chem Lab Med 46, 791-803 (2008).
3. Nordestgaard, B. G. et al. Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society. Eur Heart J 34, 3478-3490a (2013).
4. Shi, Z. et al. Familial hypercholesterolemia in China: prevalence and evidence of underdetection and undertreatment in a community population. Int J Cardiol 174, 834-836 (2014).
5. Dai, Y. F., Sun, L. Y., Zhang, X. B. & Wang, L. Y. [Research progression of LDLR mutations in Chinese Familial hypercholesterolemia]. Yi Chuan 33, 1-8 (2011).
6. Cao, S. et al. Analysis of low-density lipoprotein receptor gene mutations in a Chinese patient with clinically homozygous familial hypercholesterolemia. Chin Med J (Engl) 116, 1535-1538 (2003).
7. Wang, L. et al. Mutations in the LDL receptor gene in four Chinese homozygous familial hypercholesterolemia phenotype patients. Nutr Metab Cardiovasc Dis 19, 391-400 (2009).
8. Wang, X. et al. Genome-wide linkage scan of a pedigree with familial hypercholesterolemia suggests susceptibility loci on chromosomes 3q25-26 and 21q22. PLoS One 6, e24838 (2011).
9. Wang, H. et al. Functional characterization of two low-density lipoprotein receptor gene mutations in two Chinese patients with familial hypercholesterolemia. PLoS One 9, e92703 (2014).
10. Wu, W. F., Sun, L. Y., Pan, X. D., Yang, S. W. & Wang, L. Y. Use of targeted exome sequencing in genetic diagnosis of chinese familial hypercholesterolemia. PLoS ONE 9, (2014).
11. Ping, C. S. & Foon, C. L. Essential familial hypercholesterolemia in a Chinese family. The Journal of the Singapore Paediatric Society 13, 101-107 (1971).
12. Cai, H. J., Fan, L. M. & Huang, M. G. Homozygous familial hypercholesterolemic patients in China. Atherosclerosis 57, 303-312 (1985).
13. Hobbs, H. H., Brown, M. S. & Goldstein, J. L. Molecular genetics of the LDL receptor gene in familial hypercholesterolemia. Hum Mutat 1, 445-466 (1992).
14. Sun, X. M. et al. Familial hypercholesterolemia in China: Identification of mutations in the LDL-receptor gene that result in a receptor-negative phenotype. Arteriosclerosis and Thrombosis 14, 85-94 (1994).
15. Usifo, E. et al. Low-density lipoprotein receptor gene familial hypercholesterolemia variant database: update and pathological assessment. Ann Hum Genet 76, 387-401 (2012).
16. Adzhubei, I. A. et al. A method and server for predicting damaging missense mutations. Nat Methods 7, 248-249 (2010).
17. Leigh, S. E., Foster, A. H., Whittall, R. A., Hubbart, C. S. & Humphries, S. E. Update and analysis of the University College London low density lipoprotein receptor familial hypercholesterolemia database. Ann Hum Genet 72, 485-498 (2008).
18. Schwarz, J. M., Rodelsperger, C., Schuelke, M. & Seelow, D. MutationTaster evaluates disease-causing potential of sequence alterations. Nat Methods 7, 575-576 (2010).
19. Chang, J. H. et al. Identification and characterization of LDL receptor gene mutations in hyperlipidemic Chinese. J Lipid Res 44, 1850-1858 (2003).
20. Zakharova, F. M. et al. Familial hypercholesterolemia in St-Petersburg: the known and novel mutations found in the low density lipoprotein receptor gene in Russia. BMC Med Genet 6, 6 (2005).
21. Punzalan, F. E. et al. Low density lipoprotein-receptor (LDL-R) gene mutations among Filipinos with familial hypercholesterolemia. J Atheroscler Thromb 12, 276-283 (2005).
22. Mak, Y. T. et al. Mutations in the low-density lipoprotein receptor gene in Chinese familial hypercholesterolemia patients. Arterioscler Thromb Vasc Biol 18, 1600-1605 (1998).
23. Fouchier, S. W., Defesche, J. C., Umans-Eckenhausen, M. W. & Kastelein, J. P. The molecular basis of familial hypercholesterolemia in The Netherlands. Hum Genet 109, 602-615 (2001).
24. Chiou, K. R. & Charng, M. J. Common mutations of familial hypercholesterolemia patients in Taiwan: characteristics and implications of migrations from southeast China. Gene 498, 100-106 (2012).
25. Khoo, K. L. et al. Low-density lipoprotein receptor gene mutations in a Southeast Asian population with familial hypercholesterolemia. Clin Genet 58, 98-105 (2000).
26. Leitersdorf, E., Van der Westhuyzen, D. R., Coetzee, G. A. & Hobbs, H. H. Two common low density lipoprotein receptor gene mutations cause familial hypercholesterolemia in Afrikaners. J Clin Invest 84, 954-961 (1989).
27. Pimstone, S. N. et al. Phenotypic variation in heterozygous familial hypercholesterolemia: a comparison of Chinese patients with the same or similar mutations in the LDL receptor gene in China or Canada. Arterioscler Thromb Vasc Biol 18, 309-315 (1998).
28. Xu, Y. J. et al. Analysis of LDL receptor function and gene mutations in familial homozgous hypercholesterolemia (Chinese). Lin Chuang Xin Xue Guan Bing Za Zhi 25, 350-354 (2008).
29. Huang, J. J., Zhou, X., Chen, F. & Ha, D. W. Screening of Familial Defective Apolipoprotein B-100 (Chinese). Zhong Guo Xun Huan Za Zhi, 30-32 (1998).
30. Lin, J. et al. A novel mutation in proprotein convertase subtilisin/kexin type 9 gene leads to familial hypercholesterolemia in a Chinese family. Chin Med J (Engl) 123, 1133-1138 (2010).
31. Chiou, K. R. & Charng, M. J. Detection of mutations and large rearrangements of the low-density lipoprotein receptor gene in Taiwanese patients with familial hypercholesterolemia. Am J Cardiol 105, 1752-1758 (2010).
32. Hu, M. et al. Heterozygous familial hypercholesterolemia in Hong Kong Chinese. Study of 252 cases. International Journal of Cardiology 167, 762-767 (2013).
33. Bujo, H. et al. Clinical features of familial hypercholesterolemia in Japan in a database from 1996-1998 by the research committee of the ministry of health, labour and welfare of Japan. J Atheroscler Thromb 11, 146-151 (2004).
34. Al-Khateeb, A., Al-Talib, H., Mohamed, M. S., Yusof, Z. & Zilfalil, B. A. Phenotype-genotype analyses of clinically diagnosed Malaysian familial hypercholestrolemic patients. Adv Clin Exp Med 22, 57-67 (2013).
35. Bell, D. A. et al. Effectiveness of genetic cascade screening for familial hypercholesterolaemia using a centrally co-ordinated clinical service: An Australian experience. Atherosclerosis 239, 93-100 (2015).
36. Besseling, J. et al. Severe heterozygous familial hypercholesterolemia and risk for cardiovascular disease: a study of a cohort of 14,000 mutation carriers. Atherosclerosis 233, 219-223 (2014).
37. Humphries, S. E. et al. Mutational analysis in UK patients with a clinical diagnosis of familial hypercholesterolaemia: relationship with plasma lipid traits, heart disease risk and utility in relative tracing. J Mol Med (Berl) 84, 203-214 (2006).
38. Alonso, R. et al. Cardiovascular disease in familial hypercholesterolaemia: influence of low-density lipoprotein receptor mutation type and classic risk factors. Atherosclerosis 200, 315-321 (2008).
39. J., C. Z., Q., X. Y. & H.Y., K. Clinical coronary heart disease. Beijing: People's Military Medical Press, 77 (1998).
40. Zhou, T. H., Bahring, S. & Schuster, H. Use long chain polymerase chain reaction to research restriction fragment length polymorphism of low density lipoprotein receptor gene (Chinese) Zhong Hua Yi Xue Za Zhi 76, 465-467 (1996).
41. Zhu, D. M. et al. The application of polymerase chain reaction-single strain conf ormat ion polymorphism in the pedigree analysis of familial hypercholerolemia patients. Zhong Hua Yi Xue Yi Chuan Xue Za Zhi 17, 108-111 (2000).
42. Wang, D. et al. A Chinese homozygote of familial hypercholesterolemia: identification of a novel C263R mutation in the LDL receptor gene. J Hum Genet 46, 152-154 (2001).
43. Wang, L. Y. et al. Analysis of temperature-modulated high pe rformance liquid chromatography for detecting mutations of LDLR gene in a familial hypercholesterolemia pedigree (Chineses). Zhong Hua Jian Yan Yi Xue Za Zhi 28, 359-363 (2005).
44. Sun, L. Y. et al. Identification of the gene defect responsible for severe hypercholesterolaemia using whole-exome sequencing. Sci Rep 5, 11380 (2015).
45. Song, G. Y. et al. Research of Gene Mutation of Proprotein Convertase Subtilisin /Kexin 9 in Hypercholesterolemia. Zhong Guo Dong Mai Ying Hua Za Zhi, 731-735 (2012).
46. Jelassi, A. et al. Limited mutational heterogeneity in the LDLR gene in familial hypercholesterolemia in Tunisia. Atherosclerosis 203, 449-453 (2009).
47. Schmidt, H. & Kostner, G. M. Familial hypercholesterolemia in Austria reflects the multi-ethnic origin of our country. Atherosclerosis 148, 431-432 (2000).
48. Talmud, P. J. et al. Use of low-density lipoprotein cholesterol gene score to distinguish patients with polygenic and monogenic familial hypercholesterolaemia: a case-control study. Lancet 381, 1293-1301 (2013).
49. Villeger, L. et al. The UMD-LDLR database: additions to the software and 490 new entries to the database. Hum Mutat 20, 81-87 (2002).
50. Yamamoto, T. et al. The human LDL receptor: a cysteine-rich protein with multiple Alu sequences in its mRNA. Cell 39, 27-38 (1984).